课题基金 / 基金详情

Regulation of signaling pathway, cell cycle, and cell growth in atherosclerosis

Regulation of signaling pathway, cell cycle, and cell growth in atherosclerosis
动脉粥样硬化信号通路、细胞周期和细胞生长的调节
批准号:
13470221
负责人:
YAMADA Nobuhiro
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YAMADA Nobuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is an increasing demand to investigate the mechanisms of the formation of atherosclerosis, as diseases due to vascular complications of diabetes, hyperlipidemia and hypertension is rapidly increasing in Japan according to the recent changes in life style. Deregulation of the growth and apoptosis of vascular endotherial cells and smooth muscle cells are believed to play important roles in the formation of atherosclerosis. Therefore, it is important to study the controls of signal transduction and cell cycle of these cells during this process, which may lead to a development of the way of prevention. We have discovered the p27 CDK inhibitor, an apparent brake of the cell cycle, and have shown that CDK inhibitors, including p27, may play important roles in the regulation of cell differentiation and proliferation. Using vascular endotherial cell, we have shown that the two CDK inhibitors, p21Cip1 and p27Kip1, may have different roles in the regulations of apoptosis of the cell by the TNF-a stimuli. In the presence of insulin in the culture medium, TNF-a induced p27, where without insulin, TNF-a decreased p27 and induced p21. Apoptosis was induced more efficiently with the cells untreated with insulin, therefore, it is likely that p27 may have suppressive role, where p21 may induce apoptosis. As apoptosis of the endotherial cells are important in the formation of atherosclerotic changes, CDK inhibitors may be utilized in the prevention. Progression of atherosclerosis may be induced through a vicious cycle composed of a combination of cytokines, chemokines, adhesion molecules and extracellular matrix locally expressed by macrophage, lymphocyte, endotherial cell and smooth muscle cells. Therefore, we will investigate the effect of these molecules on the apoptosis of endotherial cells to seek for the way to prevent atherosclerosis.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Iida K.T, Yamada N, et al.: "Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway"Arterioscler.Thromb.Vasc.Biol.. 22. 380-386 (2002)
Iida K.T、Yamada N 等:“胰岛素通过磷脂酰肌醇-3-激酶依赖性途径抑制巨噬细胞系 THP-1 细胞的凋亡”Arterioscler.Thromb.Vasc.Biol.. 22. 380-386 (2002
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshikawa T, Yamada N, et al.: "Polyunsaturated fatty acids suppress sterol regulatory element-binding protein-1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements"J Biol Chem. 277. 1705-1711 (2002)
Yoshikawa T、Yamada N 等人:“多不饱和脂肪酸通过抑制肝脏 X 受体 (LXR) 与 LXR 反应元件的结合来抑制甾醇调节元件结合蛋白-1c 启动子活性”J Biol Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yahagi N, Yamada N, et al.: "Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers, but not obesity or insulin resistance in Lepob/Lepob mice"J.Biol.Chem.. 277. 19353-19357 (2002)
Yahagi N、Yamada N 等人:“甾醇调节元件结合蛋白 1 (SREBP-1) 的缺失可改善 Lepob/Lepob 小鼠的脂肪肝,但不会改善肥胖或胰岛素抵抗”J.Biol.Chem.. 277
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshikawa T., Yamada N., et al.: "Related Articles Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter"Mol Cell Biol. 21(9). 2991-3000 (2001)
Yoshikawa T.,Yamada N.,等人:“相关文章鉴定肝脏 X 受体-类视黄醇 X 受体作为甾醇调节元件结合蛋白 1c 基因启动子的激活剂”Mol Cell Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Global survey on clinical research supporting and promoting system, aiming Japanese clinical research improvement.
    • 批准号:
      19900005
    • 项目类别:
      Grant-in-Aid for Special Purposes
    • 资助金额:
      $5.76万
    • 财政年份:
      2007
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Transcriptional regulation of energy metabolism in metabolic syndrome.
    • 批准号:
      18390268
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.17万
    • 财政年份:
      2006
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Animal model for metabolic syndrome and its molecular basis.
    • 批准号:
      16390260
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2004
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    Roles of fatty acids in pathogenesis of insulin resisitance and atherosclerosis
    • 批准号:
      11470231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.34万
    • 财政年份:
      1999
    • 负责人:
      YAMADA Nobuhiro
    • 依托单位:
    海外基金